Cargando…
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
Dendritic cell (DC)-based vaccination effectively induces anti-tumor immunity, although in the majority of cases this does not translate into a durable clinical response. However, DC vaccination is characterized by a robust safety profile, making this treatment a potential candidate for effective co...
Autores principales: | Bulgarelli, Jenny, Tazzari, Marcella, Granato, Anna Maria, Ridolfi, Laura, Maiocchi, Serena, de Rosa, Francesco, Petrini, Massimiliano, Pancisi, Elena, Gentili, Giorgia, Vergani, Barbara, Piccinini, Filippo, Carbonaro, Antonella, Leone, Biagio Eugenio, Foschi, Giovanni, Ancarani, Valentina, Framarini, Massimo, Guidoboni, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794451/ https://www.ncbi.nlm.nih.gov/pubmed/31649669 http://dx.doi.org/10.3389/fimmu.2019.02353 |
Ejemplares similares
-
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
por: Ridolfi, Laura, et al.
Publicado: (2018) -
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
por: Pancisi, Elena, et al.
Publicado: (2022) -
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
por: Bulgarelli, Jenny, et al.
Publicado: (2021) -
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
por: de Rosa, Francesco, et al.
Publicado: (2014) -
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
por: Ridolfi, Laura, et al.
Publicado: (2010)